ROCKVILLE, Md., Dec. 14, 2007-The FDA today posted on its website a warning letter sent to Wyeth Pharmaceuticals Inc. over a professional journal ad for depression drug Effexor XR. The letter and promotional material is attached.
Downloads
Effexor_XR-wl.pdf
Effexor_XRPromo.pdf
No comments:
Post a Comment